FI  Bindley Capital Partners

     Office Locations:

8909 Purdue Road, Suite 500
Indianapolis, IN 46268
Phone: 317-704-4700
Fax: 317-704-4602



  • Middle Market



  • Financial Services
  • Life Sciences & Healthcare
  • Transportation & Distribution



    Bindley Capital Partners (BCP) is a private investment firm focused on the following activities: Acquiring or investing in outstanding companies; Co-investing with debt or equity sponsors; Committing capital to established third-party managers in the private and public markets. BCP manages a permanent capital base that is either supplied by or completely controlled by the principals of the firm. Bindley Capital Partners was formed in 2001 to manage the capital of William E. Bindley and a concentrated, select group of other individuals and institutions. Prior to creating Bindley Capital Partners, Mr. Bindley was the Chairman and CEO of Bindley Western Industries (NYSE: BDY), a $10 billion pharmaceutical distribution and services company he founded in 1968. BCP selectively invests in third-party managed partnerships with a variety of disciplines, including: International Private Equity; Buyouts and Growth Equity; Real Estate; Special Situations, such as secondary interests and distressed opportunities; and Hedge Funds. For Direct investments, Bindley pursues Growth Equity Investments; Management/Leveraged Buyouts; and Recapitalizations of firms in Healthcare Services, Financial Services, and Distribution/Logistics.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Clark M. Millman Chief Financial Officer and Executive Vice President
    Jennifer M. Detmer Vice President
    Keith W. Burks Partner
    Michael D. McCormick Partner
    Thomas J. Salentine President


    Portfolio companies include:

      Flex Pharma
        web link


    Recent News: